162 related articles for article (PubMed ID: 21330458)
1. Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans.
Rubbia-Brandt L; Tauzin S; Brezault C; Delucinge-Vivier C; Descombes P; Dousset B; Majno PE; Mentha G; Terris B
Mol Cancer Ther; 2011 Apr; 10(4):687-96. PubMed ID: 21330458
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model.
Robinson SM; Mann J; Vasilaki A; Mathers J; Burt AD; Oakley F; White SA; Mann DA
J Hepatol; 2013 Aug; 59(2):318-26. PubMed ID: 23624001
[TBL] [Abstract][Full Text] [Related]
3. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).
Fan CQ; Crawford JM
J Clin Exp Hepatol; 2014 Dec; 4(4):332-46. PubMed ID: 25755580
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab improves splenomegaly and decreases production of hyaluronic acid after L-OHP based chemotherapy.
Arakawa Y; Shimada M; Utsunomiya T; Imura S; Morine Y; Ikemoto T; Hanaoka J; Kanamoto M; Iwahashi S; Saito Y; Yamada S; Asanoma M; Takasu C; Bando Y
Anticancer Res; 2014 Apr; 34(4):1953-8. PubMed ID: 24692731
[TBL] [Abstract][Full Text] [Related]
5. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy.
Nishigori N; Matsumoto M; Koyama F; Hayakawa M; Hatakeyayama K; Ko S; Fujimura Y; Nakajima Y
PLoS One; 2015; 10(11):e0143136. PubMed ID: 26580395
[TBL] [Abstract][Full Text] [Related]
7. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases.
Morris-Stiff G; Tan YM; Vauthey JN
Eur J Surg Oncol; 2008 Jun; 34(6):609-14. PubMed ID: 17764887
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
Stevenson HL; Prats MM; Sasatomi E
BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766
[TBL] [Abstract][Full Text] [Related]
9. Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome.
Imai K; Emi Y; Iyama KI; Beppu T; Ogata Y; Kakeji Y; Samura H; Oki E; Akagi Y; Maehara Y; Baba H;
Eur J Surg Oncol; 2014 May; 40(5):559-566. PubMed ID: 24388740
[TBL] [Abstract][Full Text] [Related]
10. Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases.
Vreuls CP; Van Den Broek MA; Winstanley A; Koek GH; Wisse E; Dejong CH; Olde Damink SW; Bosman FT; Driessen A
Histopathology; 2012 Aug; 61(2):314-8. PubMed ID: 22571348
[TBL] [Abstract][Full Text] [Related]
11. Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization.
Narita M; Oussoultzoglou E; Chenard MP; Fuchshuber P; Rather M; Rosso E; Addeo P; Jaeck D; Bachellier P
Ann Surg Oncol; 2012 Jul; 19(7):2230-7. PubMed ID: 22402811
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases.
van den Broek MA; Vreuls CP; Winstanley A; Jansen RL; van Bijnen AA; Dello SA; Bemelmans MH; Dejong CH; Driessen A; Olde Damink SW
Ann Surg Oncol; 2013 May; 20(5):1462-9. PubMed ID: 23463086
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of serum microRNAs in hepatic sinusoidal obstruction syndrome (SOS) in rats: implication as early phase biomarkers for SOS.
Takeuchi M; Oda S; Tsuneyama K; Yokoi T
Arch Toxicol; 2018 Sep; 92(9):2947-2962. PubMed ID: 30019166
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection.
Duwe G; Knitter S; Pesthy S; Beierle AS; Bahra M; Schmelzle M; Schmuck RB; Lohneis P; Raschzok N; Öllinger R; Sinn M; Struecker B; Sauer IM; Pratschke J; Andreou A
Eur J Surg Oncol; 2017 Sep; 43(9):1668-1681. PubMed ID: 28599872
[TBL] [Abstract][Full Text] [Related]
15. Sinusoidal obstruction syndrome (SOS): A light and electron microscopy study in human liver.
Vreuls CP; Driessen A; Olde Damink SW; Koek GH; Duimel H; van den Broek MA; Dejong CH; Braet F; Wisse E
Micron; 2016 May; 84():17-22. PubMed ID: 26914502
[TBL] [Abstract][Full Text] [Related]
16. Genetic predisposition resulting in sinusoidal obstruction syndrome in a patient with resected sigmoid cancer on adjuvant oxaliplatin.
Koo SX; Chan SH; Ngeow J
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26729828
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of ultrasonography and elastography in diagnosing oxaliplatin-induced sinusoidal obstruction syndrome.
Saito R; Kawamoto Y; Nishida M; Iwai T; Kikuchi Y; Yokota I; Takagi R; Yamamura T; Ito K; Harada K; Yuki S; Komatsu Y; Sakamoto N
Int J Clin Oncol; 2022 Nov; 27(11):1780-1790. PubMed ID: 36042137
[TBL] [Abstract][Full Text] [Related]
18. Sinusoidal obstruction syndrome.
Rubbia-Brandt L
Clin Liver Dis; 2010 Nov; 14(4):651-68. PubMed ID: 21055688
[TBL] [Abstract][Full Text] [Related]
19. Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation.
Agostini J; Benoist S; Seman M; Julié C; Imbeaud S; Letourneur F; Cagnard N; Rougier P; Brouquet A; Zucman-Rossi J; Laurent-Puig P
J Hepatol; 2012 Apr; 56(4):869-76. PubMed ID: 22200551
[TBL] [Abstract][Full Text] [Related]
20. Fulminant hepatitis due to very severe sinusoidal obstruction syndrome (SOS/VOD) after autologous peripheral stem cell transplantation: a case report.
Tavernier E; Chalayer E; Cornillon J; Pouvaret A; Martignoles JA; Casteillo F; Terreaux J; Daguenet E; Guyotat D
BMC Res Notes; 2018 Jul; 11(1):436. PubMed ID: 29970140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
